Mizuho Medy Co.,Ltd. (TYO:4595)
1,785.00
-15.00 (-0.83%)
Jan 21, 2026, 3:30 PM JST
Mizuho Medy Revenue
Mizuho Medy had revenue of 2.25B JPY in the quarter ending September 30, 2025, a decrease of -32.25%. This brings the company's revenue in the last twelve months to 9.67B, down -12.03% year-over-year. In the year 2024, Mizuho Medy had annual revenue of 11.43B with 4.00% growth.
Revenue (ttm)
9.67B
Revenue Growth
-12.03%
P/S Ratio
3.52
Revenue / Employee
51.69M
Employees
187
Market Cap
34.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.43B | 440.00M | 4.00% |
| Dec 31, 2023 | 10.99B | -6.59B | -37.50% |
| Dec 31, 2022 | 17.58B | 4.44B | 33.83% |
| Dec 31, 2021 | 13.14B | 8.93B | 212.41% |
| Dec 31, 2020 | 4.21B | -2.22B | -34.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |